3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
6
Phase 2
5
Phase 2/3
2
Phase 1/2
2
Phase NA
1
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
15
Neoplasm Metastasis
3
HER2-positive Breast Cancer
2
Brain Neoplasms
2
Stomach Neoplasms
1
Solid Cancer
1
Recurrence
1
Rectal Neoplasms
1
Neoplasms
1
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Liver Neoplasms
1
Inflammatory Breast Neoplasms
1
HER2-positive Early Breast Cancer
1
Gastrointestinal Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma
1
Cancer Related Cognitive Decline
1
Breast Neoplasms, Male
1
Breast Diseases
1
Biliary Tract Neoplasms
1
Bile Duct Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Interventions
Trastuzumab
4
pertuzumab
2
Docetaxel
2
palbociclib
1
Protons
1
Paclitaxel
1
Letrozole
1
Fulvestrant
1
Fluorodeoxyglucose F18
1
Enfuvirtide
1
Doxorubicin
1
Cyclophosphamide
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
HER2-positive Breast Cancer
×
pertuzumab
×
Clear all
NCT02379585
2018-04-24
STEFNE
Western Regional Medical Center
Phase 1/2
Terminated
8 enrolled
1 chart
NCT02345772
2018-02-20
Neohttp
Western Regional Medical Center
Phase 1/2
Terminated
4 enrolled
1 chart